Matsutani A - Search Results

1

[Clinical experience of chemotherapy with cefmetazole for severe infections accompanying malignant hematological disorders].

Fujii S, Fujii Y, Inoue Y, Okubo M, Matsutani A, Kaku K, Yaga K, Kaneko T. Fujii S, et al. Among authors: matsutani a. Jpn J Antibiot. 1989 Mar;42(3):573-8. Jpn J Antibiot. 1989. PMID: 2664248 Clinical Trial. Japanese.

2

[Relationship between clinical efficiency of cefoperazone and the value of area under the time concentration curve in infectious diseases].

Kaku K, Fujii S, Ando S, Yaga K, Inoue M, Inoue Y, Okubo M, Fujii Y, Matsutani A, Azuno Y, et al. Kaku K, et al. Among authors: matsutani a. Jpn J Antibiot. 1987 Jan;40(1):77-85. Jpn J Antibiot. 1987. PMID: 3586337 Japanese.

3

[A clinical study on high dosages of cefotiam in serious infections associated with hematological disorders].

Kaku K, Inoue M, Inoue Y, Ookubo M, Matsutani A, Fujii Y, Kaneko T. Kaku K, et al. Among authors: matsutani a. Jpn J Antibiot. 1982 May;35(5):1172-6. Jpn J Antibiot. 1982. PMID: 6290702 Japanese. No abstract available.

4

Tolbutamide inhibits cAMP-dependent phosphorylation of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Aoki M, Kaku K, Inoue H, Matsutani A, Kaneko T. Aoki M, et al. Among authors: matsutani a. Diabetes. 1992 Mar;41(3):334-8. doi: 10.2337/diab.41.3.334. Diabetes. 1992. PMID: 1312965

5

Tolbutamide inhibits glucagon-induced phosphorylation of 6PF-2-K/Fru-2,6-P2ase in rat hepatocytes.

Ayame H, Matsutani A, Inoue H, Kaneko T, Kaku K. Ayame H, et al. Among authors: matsutani a. Am J Physiol. 1995 Mar;268(3 Pt 1):E391-6. doi: 10.1152/ajpendo.1995.268.3.E391. Am J Physiol. 1995. PMID: 7900785

6

Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.

Azuno Y, Kaneko T, Nishimura M, Okuya S, Nakai K, Nomiyama J, Mori K, Okafuji K, Okubo M, Matsutani A, Kamei S, Zaitsu Y, Takeuchi Y, Oka Y, Kaku K. Azuno Y, et al. Among authors: matsutani a. Bone Marrow Transplant. 1996 Jul;18(1):257-9. Bone Marrow Transplant. 1996. PMID: 8832032

7

Sequence variations of the pancreatic islet/liver glucose transporter (GLUT2) gene in Japanese subjects with noninsulin dependent diabetes mellitus.

Matsubara A, Tanizawa Y, Matsutani A, Kaneko T, Kaku K. Matsubara A, et al. Among authors: matsutani a. J Clin Endocrinol Metab. 1995 Nov;80(11):3131-5. doi: 10.1210/jcem.80.11.7593414. J Clin Endocrinol Metab. 1995. PMID: 7593414

8

HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.

Tao T, Tanizawa Y, Matsutani A, Matsubara A, Kaneko T, Kaku K. Tao T, et al. Among authors: matsutani a. Diabetologia. 1995 Aug;38(8):942-7. doi: 10.1007/BF00400583. Diabetologia. 1995. PMID: 7589880

9

Effects of tolbutamide on fructose-2,6-bisphosphate formation and ketogenesis in hepatocytes from diabetic rats.

Mori K, Kaku K, Inoue H, Aoki M, Matsutani A, Kaneko T. Mori K, et al. Among authors: matsutani a. Metabolism. 1992 Jul;41(7):706-10. doi: 10.1016/0026-0495(92)90308-w. Metabolism. 1992. PMID: 1535678

10

Possible mechanism of proteolysis for the extrapancreatic action of tolbutamide.

Matsutani A, Kaku K, Aoki M, Mori K, Matsuda M, Kaneko T. Matsutani A, et al. Diabetes Res Clin Pract. 1991 Apr;12(1):35-40. doi: 10.1016/0168-8227(91)90128-z. Diabetes Res Clin Pract. 1991. PMID: 1855439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters